Increased fracture risk, particularly in the hips and ertebrae, has been frequently described among patients on high-dose glucocorticoids.

• 骨折风险的增加，特别是髋骨和椎骨骨折的风险增加，在使用大剂量糖皮质激素的患者中经常见到。